AUA 2017: Pure bipolar plasma vaporization of the prostate: 5-year follow-up from a prospective 3D ultrasound volumetry study.

Boston, MA (UroToday.com) An Alternative treatment modality to conventional transurethral resection of the prostate (TURP) is bipolar plasma vaporization (BPV), which has been shown to have improved coagulation properties. There has been many studies which looked at short-term outcomes of BPV; however, long-term outcome data is lacking. Dr. Kranzbuhler and team at University Hospital Zurich then sought the long-term outcomes of BPC, and the extent of prostate tissue removal.

In this study, 75 men undergoing BPV were prospectively investigated. The authors in the study measured prostate volume using planimetric volumetric, and assessed functional outcome parameters. They found that patients’s, who underwent BPV, relative volume reduction increased significantly up to 12 months from postoperative. However, after 12 months, relative volume reduction remained stable all the way to 5 years. All clinical parameters also improved significantly and remained stable postoperatively.

In conclusion, the authors note that BPV works efficiently both short-term and long-term due to low-intra and postoperative morbidity in combination with excellent functional outcome and durable prostate volume reduction This confirms the author’s belief that BPV is a better minimally invasive alternative for TURP.

Presented by: B. Kranzbuhler, MD, Department of Urology, University Hospital Zurich

Authors: B. Kranzbuhler, O. Gross, C.D. Fankhauser, M.S. Wettstein, N.C. Grossman, D. Eberli, T. Sulser, C. Polet, T. Hermanns

Affiliation: Department of Urology, University Hospital Zurich

Written By: Nobel Nguyen, MD, Department of Urology, University of California, Irvine

at the 2017 AUA Annual Meeting - May 12 - 16, 2017 – Boston, Massachusetts, USA

Login